UBS Group’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-280,745
| Closed | -$337K | – | 10300 |
|
|
2023
Q1 | $337K | Buy |
280,745
+256,678
| +1,067% | +$571K | ﹤0.01% | 4990 |
|
|
2022
Q4 | $34.2K | Buy |
24,067
+18,101
| +303% | +$38.8K | ﹤0.01% | 7109 |
|
|
2022
Q3 | $14K | Sell |
5,966
-30,017
| -83% | -$100K | ﹤0.01% | 7971 |
|
|
2022
Q2 | $81K | Buy |
35,983
+31,430
| +690% | +$117K | ﹤0.01% | 5584 |
|
|
2022
Q1 | $31K | Sell |
4,553
-27,660
| -86% | -$236K | ﹤0.01% | 6980 |
|
|
2021
Q4 | $292K | Buy |
32,213
+27,568
| +593% | +$256K | ﹤0.01% | 5387 |
|
|
2021
Q3 | $47K | Sell |
4,645
-10,912
| -70% | -$120K | ﹤0.01% | 6388 |
|
|
2021
Q2 | $200K | Sell |
15,557
-33,980
| -69% | -$466K | ﹤0.01% | 5348 |
|
|
2021
Q1 | $700K | Sell |
49,537
-25,878
| -34% | -$356K | ﹤0.01% | 4590 |
|
|
2020
Q4 | $804K | Buy |
75,415
+67,573
| +862% | +$614K | ﹤0.01% | 4195 |
|
|
2020
Q3 | $60K | Sell |
7,842
-82,848
| -91% | -$609K | ﹤0.01% | 5514 |
|
|
2020
Q2 | $550K | Sell |
90,690
-138,546
| -60% | -$683K | ﹤0.01% | 4052 |
|
|
2020
Q1 | $807K | Sell |
229,236
-49,389
| -18% | -$418K | ﹤0.01% | 3541 |
|
|
2019
Q4 | $2.94M | Buy |
278,625
+66,034
| +31% | +$586K | ﹤0.01% | 3158 |
|
|
2019
Q3 | $2.38M | Sell |
212,591
-9,304
| -4% | -$110K | ﹤0.01% | 3130 |
|
|
2019
Q2 | $2.03M | Sell |
221,895
-58,303
| -21% | -$608K | ﹤0.01% | 3138 |
|
|
2019
Q1 | $3.1M | Sell |
280,198
-76,519
| -21% | -$535K | ﹤0.01% | 2600 |
|
|
2018
Q4 | $889K | Sell |
356,717
-17,873
| -5% | -$64.1K | ﹤0.01% | 3774 |
|
|
2018
Q3 | $1.69M | Buy |
374,590
+29,099
| +8% | +$212K | ﹤0.01% | 3369 |
|
|
2018
Q2 | $4.13M | Sell |
345,491
-61,658
| -15% | -$825K | ﹤0.01% | 2515 |
|
|
2018
Q1 | $6.27M | Buy |
407,149
+96,921
| +31% | +$1.62M | ﹤0.01% | 2107 |
|
|
2017
Q4 | $5.07M | Buy |
310,228
+124,633
| +67% | +$2.41M | ﹤0.01% | 2345 |
|
|
2017
Q3 | $4.24M | Buy |
185,595
+38,001
| +26% | +$810K | ﹤0.01% | 2371 |
|
|
2017
Q2 | $4.13M | Buy |
147,594
+62,516
| +73% | +$1.73M | ﹤0.01% | 2325 |
|
|
2017
Q1 | $2.61M | Sell |
85,078
-11,927
| -12% | -$337K | ﹤0.01% | 2688 |
|
|
2016
Q4 | $2.44M | Buy |
97,005
+9,273
| +11% | +$219K | ﹤0.01% | 2739 |
|
|
2016
Q3 | $2.17M | Buy |
87,732
+5,407
| +7% | +$144K | ﹤0.01% | 2757 |
|
|
2016
Q2 | $2.04M | Buy |
82,325
+23,997
| +41% | +$618K | ﹤0.01% | 2759 |
|
|
2016
Q1 | $1.69M | Sell |
58,328
-2,924
| -5% | -$76.4K | ﹤0.01% | 2826 |
|
|
2015
Q4 | $1.84M | Sell |
61,252
-1,924
| -3% | -$65.4K | ﹤0.01% | 2867 |
|
|
2015
Q3 | $1.88M | Sell |
63,176
-33,035
| -34% | -$1.07M | ﹤0.01% | 2797 |
|
|
2015
Q2 | $3.37M | Buy |
96,211
+32,574
| +51% | +$1.15M | ﹤0.01% | 2475 |
|
|
2015
Q1 | $2.26M | Sell |
63,637
-27,327
| -30% | -$921K | ﹤0.01% | 2821 |
|
|
2014
Q4 | $3.15M | Buy |
+90,964
| New | +$3.21M | ﹤0.01% | 2478 |
|
Other funds holding DBD
BFIM
HNB
UBS Group's DBD Position: Q2 2023 in Review
UBS Group sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 280,745 shares — an estimated $337K sold.
UBS Group first reported a position in DBD in Q4 2014 and held it in 34 quarters. The position peaked at $6.27M in Q1 2018. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.
- UBS Group reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
- UBS Group sold 280,745 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $337K.
- UBS Group first reported a position in Diebold Nixdorf Incorporated in Q4 2014 and held it in 34 quarters.
- UBS Group's Diebold Nixdorf Incorporated position peaked at $6.27M in Q1 2018.
- 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.